Skip to main content
SpringerLink
Log in

Die Bedeutung der Dosisintensität bei fortgeschrittenen Harnblasenkarzinomen

  • Conference paper
Urologische Beckenchirurgie

  • 25 Accesses

Zusammenfassung

Es ist eine Tatsache, daß in vitro auf jeden Fall eine steile Dosis-/Wirkungsbe- ziehung zwischen den verschiedenen Substanzen sowie den verschiedenen Tumoren besteht, und daß selbst eine erworbene oder primär bestehende Resistenz von Tumorzellen durch Erhöhung der Dosis der jeweiligen Substanz überwunden werden kann.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. De Vita VT (1986) Dose response is alive and well. J Clin Oncol 4(8): 1157–1159

    Google Scholar 

  2. Dreicer R et al. (1989) Pilot study of perioperative MVAC for bladder cancers: An ECOG study. ASCO Abstract Nr 523

    Google Scholar 

  3. Fossa D Persönliche Mitteilung

    Google Scholar 

  4. Hryniuk W (1988) More is better. J Clin Oncol 6(9): 1365–1367

    PubMed  CAS  Google Scholar 

  5. Hryniuk W, Bush H (1984) The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2(11): 1281–1288

    PubMed  CAS  Google Scholar 

  6. Logothetis C et al. (1989) Escalated MVAC with recombinant human granulocytes macrophage stimulating factor for patients with advanced and chemotherapy refractory urothelial tumors: A phase I study. ASCO Abstract Nr. 514

    Google Scholar 

  7. Meissner DJ et al. (1989) Neo-adjuvant MVAC chemotherapy for locally advanced transitional cell cancer of the bladder. ASCO Abstract Nr. 532

    Google Scholar 

  8. O’Brien RN et al. (1977) Dose response evaluation of Adriamycin in human neoplacia. Cancer 39:1940–1948

    Article  Google Scholar 

  9. Splinter T et al. (1989) EORTC-GU Group Study 30851 : A phase II study of upfront chemotherapy in patients with invasive bladder cancer. ASCO Abstract Nr. 541

    Google Scholar 

  10. Sternberg CN et al. (1989) Patterns of response : survival and relapse in advanced urothel—ial cancer following MVAC therapy. ASCO Abstract Nr. 501

    Google Scholar 

  11. Yagoda A (1987) Chemotherapy of urothelial tract tumors. Cancer 60:574

    Article  PubMed  CAS  Google Scholar 

  12. Yagoda A (1989) The role of cisplatin-based chemotherapy in advanced urothelial tract cancer. Seminars in Oncology 16(4) [Suppl. 6]: 98–104

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung Medizin/Onkologie, Farmitalia Carlo Erba GmbH, Merzhauser Str. 112, D-7800, Freiburg, Deutschland

    K. Burk

  2. Urologische Abteilung, Krankenhaus am Urban, Dieffenbachstr. 1, D-1000, Berlin 61, Deutschland

    L. Weissbach

  3. Urologische Klinik, RWTH Aachen, Pauwelstr., D-5100, Aachen, Deutschland

    G. Jakse

  4. Urologische Abteilung, Universitätsklinik Ulm, Prittwitzstr. 43, D-7900, Ulm, Deutschland

    U. K. Wenderoth

Authors
  1. K. Burk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Weissbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Jakse
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. K. Wenderoth
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinikum rechts der Isar, Urologische Klinik und Poliklinik der Technischen Universität München, Ismaninger Straße 22, D-8000, München 80, Deutschland

    Rudolf Hartung  & Wolfgang Kropp  & 

  2. Urologische Abteilung, Allgemeine Poliklinik der Stadt Wien, Mariannengasse 10, A-1090, Wien, Austria

    Wilhelm Hübner

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Burk, K., Weissbach, L., Jakse, G., Wenderoth, U.K. (1991). Die Bedeutung der Dosisintensität bei fortgeschrittenen Harnblasenkarzinomen. In: Hartung, R., Hübner, W., Kropp, W. (eds) Urologische Beckenchirurgie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76138-6_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76138-6_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76139-3

  • Online ISBN: 978-3-642-76138-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation